Targeting fanconi anemia/BRCA2 pathway defects in cancer: The significance of preclinical pharmacogenomic models
- Eike Gallmeier
- , Scott E. Kern
Research output: Contribution to journal › Review article › peer-review
37
Link opens in a new tab
Scopus
citations